Browsing by Author "Phoenix, David A"
Now showing items 1-3 of 3
-
Liposome mediated-CYP1A1 gene silencing nanomedicine prepared using lipid film-coated proliposomes as a potential treatment strategy of lung cancer.
Zhang, Mengtian; Wang, Qin; Wan, Ka-Wai; Ahmed, Waqar; Phoenix, David A; Zhang, Zhirong; Elrayess, Mohamed A; Elhissi, Abdelbary; Sun, Xun... more authors ... less authors ( Elsevier , 2019 , Article)The occurrence of lung cancer is linked with tobacco smoking, mainly through the generation of polycyclic aromatic hydrocarbons (PAHs). Elevated activity of cytochrome P4501A1 (CYP1A1) plays an important role in the metabolic ... -
PEGylated graphene oxide for tumor-targeted delivery of paclitaxel
Xu, Hongyang; Fan, Minmin; Elhissi, Abdelbary MA; Zhang, Zhirong; Wan, Ka-Wai; Ahmed, Waqar; Phoenix, David A; Sun, Xun... more authors ... less authors ( Future Medicine Ltd. , 2015 , Article)Aim: The graphene oxide (GO) sheet has been considered one of the most promising carbon derivatives in the field of material science for the past few years and has shown excellent tumor-targeting ability, biocompatibility ... -
Taxane anticancer formulations: challenges and achievements
Abdelbary M.A., Elhissi; Mahmood, Rukhsana; Parveen, Ishrat; Vali, Asma; Najlah, Mohammad; Phoenix, David A.; Ahmed, Waqar... more authors ... less authors ( Academic Press , 2020 , Book chapter)Taxanes represent a prominent anticancer family. Paclitaxel and docetaxel are the most well-known taxanes owing to their activity against many types of cancers. The poor solubility of taxanes in water is a major obstacle ...